Scrip's Pharmaceutical Company League Tables 2007

Table of Contents

CHAPTER 1 METHODOLGY AND DEFINITIONS

• 1.1 What are Scrip' s Pharmaceutical Company League Tables?
• 1.2 How is the data collected?

CHAPTER 2 LEADING COMPANIES RANKED BY TOTAL REVENUE

• 2.1 Commentary

CHAPTER 3 LEADING COMPANIES RANKED BY GROWTH IN TOTAL REVENUE

• 3.1 Commentary

CHAPTER 4 LEADING COMPANIES RANKED BY TOTAL SALES

• 4.1 Commentary

CHAPTER 5 LEADING COMPANIES RANKED BY PHARMACEUTICAL SALES

• 5.1 Commentary

CHAPTER 6 LEADING COMPANIES RANKED BY SHARE OF THE PHARMACEUTICAL MARKET

• 6.1 Commentary

CHAPTER 7 LEADING COMPANIES RANKED BY TOTAL OPERTAING PROFIT

• 7.1 Commentary

CHAPTER 8 LEADING COMPANIES RANKED BY TOTAL OPERATING PROFIT MARGIN

• 8.1 Commentary

CHAPTER 9 LEADING COMPANIES RANKED BY NET PROFIT

• 9.1 Commentary

CHAPTER 10 LEADING COMPANIES RANKED BY EARNINGS PER SHARE

• 10.1 Commentary

CHAPTER 11 LEADING COMPANIES RANKED BY INCOME PER EMPLOYEE

• 11.1 Commentary

CHAPTER 12 LEADING COMPANIES RANKED BY PHARMACEUTICAL OPERATING PROFIT

• 12.1 Commentary

CHAPTER 13 LEADING COMPANIES RANKED BY PHARMACEUTICAL OPERATING PROFIT MARGIN

• 13.1 Commentary

CHAPTER 14 LEADING COMPANIES RANKED BY TOTAL R&D EXPENDITURE

• 14.1 Commentary

CHAPTER 15 LEADING COMPANIES RANKED BY TOTAL R&D EXPENDITURE AS

• A PERCENTAGE OF TOTAL SALES
• 15.1 Commentary

CHAPTER 16 LEADING COMPANIES RANKED BY TOTAL R&D EXPENDITURE AS A PERCENTAGE OF TOTAL REVENUE

• 16.1 Commentary

CHAPTER 17 LEADING COMPANIES RANKED BY PHARMACEUTICAL R&D EXPENDITURE

• 17.1 Commentary

CHAPTER 18 LEADING COMPANIES RANKED BY TOTAL CAPITAL EXPENDITURE

• 18.1 Commentary

CHAPTER 19 LEADING COMPANIES RANKED BY SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

• 19.1 Commentary

CHAPTER 20 LEADING COMPANIES RANKED BY TOTAL ASSETS

• 20.1 Commentary

CHAPTER 21 LEADING COMPANIES RANKED BY CURRENT ASSETS

• 21.1 Commentary

CHAPTER 22 LEADING COMPANIES RANKED BY WORKING CAPITAL

• 22.1 Commentary

CHAPTER 23 LEADING COMPANIES RANKED BY PHARMACEUTICAL ASSETS

• 23.1 Commentary

CHAPTER 24 LEADING BIOTECHNOLOGY COMPANIES RANKED BY TOTAL REVENUE

• 24.1 Commentary

CHAPTER 25 LEADING BIOTECHNOLOGY COMPANIES RANKED BY R&D EXPENDITURE

• 25.1 Commentary

CHAPTER 26 LEADING BIOTECHNOLOGY COMPANIES RANKED BY R&D EXPENDITURE AS A PERCENTAGE OF TOTAL REVENUE

• 26.1 Commentary

APPENDIX 1 EXCHANGE RATES 2005 AND 2006

APPENDIX 2 MERGERS & ACQUISITIONS OF NOTE

LIST OF TABLES

• Table 2.1 Leading Companies Ranked by Total Revenue
• Table 3.1 Leading Companies Ranked by Growth in Total Revenue
• Table 4.1 Leading Companies Ranked by Total Sales
• Table 5.1 Leading Companies Ranked by Pharmaceutical Sales
• Table 6.1 Leading Companies Ranked by Share of the Pharmaceutical Market
• Table 7.1 Leading Companies Ranked by Total Operating Profit
• Table 8.1 Leading Companies Ranked by Total Operating Profit Margin
• Table 9.1 Leading Companies Ranked by Net Profit
• Table 10.1 Leading Companies Ranked by Earnings per Share
• Table 11.1 Leading Companies Ranked by Income per Employee
• Table 12.1 Leading Companies Ranked by Pharmaceutical Operating Profit
• Table 13.1 Leading Companies Ranked by Pharmaceutical Operating Profit Margin
• Table 14.1 Leading Companies Ranked by Total R&D Expenditure
• Table 15.1 Leading Companies Ranked by Total R&D Expenditure as a Percentage of Total Sales
• Table 16.1 Leading Companies Ranked by Total R&D Expenditure as a Percentage of Total Revenue
• Table 17.1 Leading Companies Ranked by Pharmaceutical R&D Expenditure
• Table 18.1 Leading Companies Ranked by Total Capital Expenditure
• Table 19.1 Leading Companies Ranked by Selling, General and Administrative (SG&A) Expenses
• Table 20.1 Leading Companies Ranked by Total Assets
• Table 21.1 Leading Companies Ranked by Current Assets
• Table 22.1 Leading Companies Ranked by Working Capital
• Table 23.1 Leading Companies Ranked by Pharmaceutical Assets
• Table 24.1 Leading Biotechnology Companies Ranked by Total Revenue
• Table 25.1 Leading Biotechnology Companies Ranked by R&D Expenditure
• Table 26.1 Leading Biotechnology Companies Ranked by R&D Expenditure as a Percentage of Total Revenue